MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
$164,383K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Prescription reimbursement liabi...
    • Depreciation and amortization
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Repurchases of class a common st...
    • Accounts receivable
    • Prescription reimbursement asset...
    • Others

Cash Flow
2025-12-31
Net income (loss)
30,439
Depreciation and amortization
85,218
Loss on extinguishment of debt
0
Amortization of debt issuance costs and discounts
1,768
Non-cash operating lease expense
4,007
Stock-based compensation expense
76,626
Deferred income taxes
20,071
Loss on operating lease assets
4,409
Loss on disposal of capitalized software
0
Loss on minority equity interest investment
0
Other
1,810
Accounts receivable
88,016
Prescription reimbursement assets
75,387
Prepaid expenses and other assets
8,387
Accounts payable
4,103
Prescription reimbursement liabilities
114,341
Accrued expenses and other current liabilities
1,185
Operating lease liabilities
-6,269
Other liabilities
1,986
Net cash provided by operating activities
167,904
Purchase of property and equipment
3,521
Acquisitions
43,440
Capitalized software
70,499
Other
2,500
Net cash used in investing activities
-119,960
Proceeds from long-term debt
0
Payments on long-term debt
5,000
Payments of debt issuance costs
0
Repurchases of class a common stock
216,372
Proceeds from exercise of stock options
61
Employee taxes paid related to net share settlement of equity awards
14,467
Proceeds from employee stock purchase plan
1,308
Net cash used in financing activities
-234,470
Net change in cash and cash equivalents
-186,526
Beginning of period
448,346
End of period
261,820
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Prescription reimbursementliabilities$114,341K Depreciation andamortization$85,218K Stock-based compensationexpense$76,626K Net income (loss)$30,439K Deferred income taxes$20,071K Loss on operatinglease assets$4,409K Accounts payable$4,103K Non-cash operating leaseexpense$4,007K Other liabilities$1,986K Other$1,810K Amortization of debt issuancecosts and discounts$1,768K Accrued expenses andother current...$1,185K Net cash provided byoperating activities$167,904K Canceled cashflow$178,059K Net change in cashand cash...-$186,526K Canceled cashflow$167,904K Proceeds from employeestock purchase plan$1,308K Proceeds from exercise ofstock options$61K Accounts receivable$88,016K Prescription reimbursementassets$75,387K Prepaid expenses andother assets$8,387K Operating leaseliabilities-$6,269K Net cash used infinancing activities-$234,470K Canceled cashflow$1,369K Net cash used ininvesting activities-$119,960K Repurchases of class a commonstock$216,372K Employee taxes paidrelated to net share...$14,467K Payments on long-termdebt$5,000K Capitalized software$70,499K Acquisitions$43,440K Purchase of property andequipment$3,521K Other$2,500K

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc. (GDRX)